Pharma companies overcharged consumers by ₹10,000 crore despite price controls: data

Pharmaceutical companies have allegedly overcharged consumers by more than ₹10,000 crore despite price caps imposed on essential medicines, according to data from the National Pharmaceutical Pricing Authority (NPPA).

The regulator has raised recovery demands under Drug Price Control Orders for charging prices higher than approved limits.

As of September 2025, NPPA has raised total demands of ₹10,013.3 crore, of which ₹8,526.1 crore remains unrecovered.

A significant portion of the pending amount—around ₹5,938.7 crore—is currently under litigation or dispute, with companies challenging NPPA’s recovery orders in courts.

Recovery has remained slow, with only ₹1,487.1 crore collected so far. NPPA data also shows that recovery in the first six months of 2025–26 increased compared to the previous year, though legal challenges continue to delay enforcement against several major pharmaceutical firms.

Recoveries raised (including interest) during FY 2025–26

Swiss Garnier Genexiaa Sciences Pvt Ltd – Nifutin 100 mg tablets: ₹12.81 crore

Torrent Pharmaceuticals – Regestrone CR 10 tablets: ₹6.58 crore

USV Ltd – Clopidogrel 75 mg tablets: ₹4.54 crore

Unichem Laboratories Ltd – Trilostar 6.25 tablets: ₹3.32 crore

Lupin Ltd – Telista 20 tablets: ₹2.37 crore

(Recoveries made up to September 2025 include ₹3.03 crore from Torrent Pharmaceuticals, ₹1.86 crore from USV Ltd, ₹1.35 crore from Unichem Laboratories Ltd, and ₹87.86 lakh from Lupin Ltd)

Related Posts

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

On Thursday, Congress workers held protests against the “degrading medical conditions of Rajasthan” and attempted to enter the hospital premises. Rajasthan Health Minister Gajendra Singh Khinvsar’s remarks about women diagnosed…

Price cap on 2 key cancer drugs increased by 50%

NEW DELHI: Amid concerns over shortages of two critical cancer medicines, National Pharmaceutical Pricing Authority has approved a 50% hike in ceiling prices of Carboplatin and Cisplatin injections, citing escalating…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

Price cap on 2 key cancer drugs increased by 50%

Price cap on 2 key cancer drugs increased by 50%

Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case

No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case